| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695758 | Gynecologic Oncology | 2017 | 7 Pages |
Abstract
The US rate of radical cytoreductive surgery for advanced ovarian cancer is increasing. At high-volume hospitals, patients receive more radical surgery with fewer complications, supporting further study of a centralized ovarian cancer care model.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
A.K. Sinno, X. Li, R.E. Thompson, E.J. III, K.L. Levinson, R.L. Stone, S.M. Temkin, A.N. Fader, D.S. Chi, K. Long Roche,